aminoglutethimide has been researched along with 17 alpha-hydroxyprogesterone caproate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, XS; Zhang, X | 1 |
| Cao, B; Zhang, X | 1 |
2 trial(s) available for aminoglutethimide and 17 alpha-hydroxyprogesterone caproate
| Article | Year |
|---|---|
[Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Endometrial Neoplasms; Estradiol; Female; Humans; Hydroxyprogesterones; Middle Aged; Progesterone | 1995 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |